New Sementis CEO to Advance Vaccine Technology
September 2023 Biotechnology company Sementis will advance its position at the forefront of vaccine technology with the...
Sementis has exciting news.
We’re pleased to announce that we’ve been awarded a $3 million Federal Government grant to help fund the advancement of the Sementis Copenhagen Vector (SCV) platform.
This CRC-P (Cooperative Research Centre Project) grant is most welcome as we collaborate with industry partners to scale up to phase one of clinical trials.
We look forward to sharing more information with you once we have a signed formal agreement in place with our partners.
This $3 million funding is a vote of confidence from the Federal Government in the Sementis SCV platform. We’re grateful to the Department of Industry, Science and Resources as we continue to develop Australia’s most advanced viral vector vaccine platform technology to fight a wide range of diseases into the future.
We remain committed to building national sovereignty to address future pandemics and threats to public health.
Thank you to our hardworking, dedicated team at Sementis for getting us here.
You can read today’s announcement by Federal Minister for Industry, Science and Technology, Ed Husic MP here: https://lnkd.in/gauRuChD